# A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

> clinical trial · VERIFIED · 2026-06-22

Status: RECRUITING · Sponsor: ETOP IBCSG Partners Foundation · Condition: Non-Small Cell Lung Cancer

- Company: ETOP IBCSG Partners Foundation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06931717

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.